CLBTCLBTTechnology · Software - Infrastructure

CLBT Stock Forecast: Cellebrite DI Ltd. Price Predictions for 2026-2027

Last close, 18 Nov 2026
$11
+4.79% on the day

The 8 Wall Street analysts covering Cellebrite DI Ltd. hold a median 12-month price target of $15 — +34.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 49 of 100 as at 17 Nov 2026 — in the lower half.

Market cap
$2.8B
Ticker Nerd rank
49/ 100
Median analyst target
$15
Analysts covering
8
Revenue$131.1M+15.8% y/y
Operating income$6.9M
Net income$6.4M
Free cash flow$6.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−12.1%
1M
+1.2%
YTD
−38.1%
1Y
−39.0%
From 52W high
−42.0%
From 52W low
+6.9%
$10
$19
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CLBT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Cellebrite DI Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Nov 2026
49/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
93
Value
67
Accruals
64
Revisions
63
Volatility
41
Growth
41
Issuance
34
Size
31
Momentum
17

Quality (93): The business earns solid, repeatable profits on what it owns.

Momentum (17): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CLBT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CLBT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$12$14$16$18$20Jan 26Apr 26Jul 26Oct 26CLBTHigh $20Median $15Low $14

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says8 analysts
8 Buy0 Hold0 Sell
Low $14Median $15High $20

The green dot is the last close — the median target sits +34.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
13 Nov 2026JP MorganMaintainsOverweight$16 → $15
12 Nov 2026NeedhamMaintainsBuy$13 → $14
15 Sept 2026DA DavidsonMaintainsBuy$15
15 Sept 2026DA DavidsonMaintainsBuy—
14 Aug 2026DA DavidsonMaintainsBuy—
14 Aug 2026DA DavidsonMaintainsBuy$22 → $15
14 Aug 2026JP MorganMaintainsOverweight$20 → $16
14 Aug 2026JP MorganMaintainsOverweight—
14 Aug 2026Lake StreetMaintainsBuy$21 → $15
14 Aug 2026Lake StreetMaintainsBuy—
14 Aug 2026NeedhamMaintainsBuy$15 → $13
14 Aug 2026NeedhamMaintainsBuy—
6 Aug 2026DA DavidsonMaintainsBuy$20 → $22
6 Aug 2026DA DavidsonMaintainsBuy—
27 May 2026DA DavidsonInitiatesBuy$20
27 May 2026DA DavidsonInitiatesBuy—
15 May 2026NeedhamMaintainsBuy—
12 Feb 2026NeedhamMaintainsBuy—
13 Nov 2025B of A SecuritiesMaintainsBuy—
13 Nov 2025JP MorganMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CLBT appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CLBT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Nov 2026, Cellebrite DI Ltd. returned −39.0% against +12.2% for the S&P 500, dividends included.

CLBT vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120Jan 26Apr 26Jul 26Oct 26CLBTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CLBT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+6.3%
Analysts raising
3
Analysts cutting
4
Fundamentals

Cellebrite DI Ltd. (CLBT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
44.5×

Cheaper than 16% of US stocks

Price / sales
5.2×

Cheaper than 22% of US stocks

Price / book
4.8×

Cheaper than 19% of US stocks

EV / EBITDA
26.0×

Cheaper than 10% of US stocks

Growth & margins
Revenue growth (YoY)
18.2%

Higher than 67% of US stocks

Earnings growth (YoY)
32.0%

Higher than 67% of US stocks

Gross margin
80.8%

Higher than 92% of US stocks

Operating margin
11.9%

Higher than 69% of US stocks

Net margin
12.1%

Higher than 73% of US stocks

Returns & dividend
Return on equity
12.7%

Higher than 69% of US stocks

Return on assets
4.2%

Higher than 72% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Cellebrite DI Ltd. (CLBT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Cellebrite DI Ltd. has a market value of $2.8B and an enterprise value of $2.4B.

  • Revenue in the twelve months to 30 June 2026: $514.3M. The latest quarter grew 18.2% year on year.

  • Net income over the same four quarters: $58.8M, a 11.4% net margin.

  • Diluted earnings per share, trailing twelve months: $0.22.

  • Free cash flow in the twelve months to 30 June 2026: $128.6M.

  • Shares outstanding: 250.8M.

  • Trailing P/E: 44.5×; forward P/E: 16.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Cellebrite DI Ltd. employs 1,285 people — $400K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 17 Nov 2026

Data provided by Twelve Data

Peers

CLBT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Infrastructure
CompanyMarket capTKN rank
CLBTCellebrite DI Ltd.$2.8B49
EEFTEuronet Worldwide, Inc.$2.6B70
FLYWFlywire Corp.$2.6B82
WIXWix.com Ltd.$2.7B59
PAYOPayoneer Global, Inc.$2.4B50
GCTGigaCloud Technology, Inc.$2.3B83
RAMPLiveRamp Holdings, Inc.$2.3B—

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Cellebrite DI Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CLBT news & analysis

Cellebrite DI: Continuous Innovation Including AI Can Drive Growth

Seeking Alpha · 16 Nov 2026positive

The article says Cellebrite’s Q3 revenue rose 18% to $149 million and ARR grew 20% to $528.5 million, with federal and international demand supporting growth. The company raised its 2026 adjusted EBITDA guidance to $163 million–$166 million.

Why it matters — The reported growth, demand sources, and higher guidance are relevant indicators for investors following CLBT’s business performance.

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

PRNewsWire · 13 Nov 2026negative

A PRNewsWire notice says Levi & Korsinsky is investigating Cellebrite DI after its shares fell about 14% following third-quarter results that exceeded key estimates but included another reduction to full-year revenue guidance. The notice says investors who lost money may have legal rights.

Why it matters — The investigation notice and revenue-guidance reduction may be relevant to CLBT watchers assessing the company’s recent results and investor concerns.

Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript

Seeking Alpha · 12 Nov 2026neutral

Cellebrite DI Ltd. held its Q3 2026 earnings call on November 12, 2026, with company executives and analysts participating. The excerpt lists the participants but provides no discussion of results or business updates.

Why it matters — CLBT watchers can note the call took place, but the supplied excerpt contains no substantive financial or operational information.

Cellebrite DI Q3 Earnings Call Highlights

MarketBeat · 12 Nov 2026positive

Cellebrite DI reported third-quarter revenue growth of 18% and annual recurring revenue growth of 20%. International sales and improving U.S. federal demand helped the digital forensics company exceed its guidance.

Why it matters — The growth and demand trends provide CLBT watchers with an update on the company’s recent operating performance.

Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates

Zacks Investment Research · 12 Nov 2026neutral

Cellebrite DI Ltd. reported quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.

Why it matters — The result provides CLBT watchers with an update on the company’s quarterly earnings relative to consensus expectations.

FAQ

Frequently asked questions about CLBT stock

What is the CLBT stock price forecast for 2026-2027?

The 8 Wall Street analysts covering Cellebrite DI Ltd. have a median 12-month price target of $15, with estimates ranging from $14 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CLBT stock a buy right now?

Of the 8 analysts covering Cellebrite DI Ltd., 8 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Cellebrite DI Ltd. 49 out of 100 across roughly 4,600 US stocks as at 17 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CLBT?

As at 17 Nov 2026, Cellebrite DI Ltd. ranks 49 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (93 of 100).

Will CLBT stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +34.4% from the last close, and Ticker Nerd's factor model ranks Cellebrite DI Ltd. 49 out of 100 as at 17 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CLBT stock forecast for 2030?

No analyst covering Cellebrite DI Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLBT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $14 to $20 over the next 12 months.

How has CLBT stock performed over the past year?

Cellebrite DI Ltd. returned -39.0% over the 12 months to 18 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Cellebrite DI Ltd. do?

Cellebrite DI Ltd. is a digital intelligence software company that provides tools for legally sanctioned investigations across public and private sector environments.

What is the latest news on CLBT?

The most recent item we track (Seeking Alpha, 16 Nov 2026): "Cellebrite DI: Continuous Innovation Including AI Can Drive Growth". The article says Cellebrite’s Q3 revenue rose 18% to $149 million and ARR grew 20% to $528.5 million, with federal and international demand supporting growth. The company raised its 2026 adjusted EBITDA guidance to $163 million–$166 million.

Company

About Cellebrite DI Ltd.

Cellebrite DI Ltd. is a digital intelligence software company that provides tools for legally sanctioned investigations across public and private sector environments. Cellebrite DI Ltd. offers a platform used to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital evidence throughout the investigative process. Its products and services support law enforcement, government agencies, and enterprise customers handling complex cases involving mobile devices, cloud data, and other digital sources. The company also provides training, advisory, advanced services, and technical support to help customers use its investigative workflows effectively. Cellebrite DI Ltd. serves a broad range of use cases, including cybercrime, financial crime, organized crime, counterterrorism, border control, and corporate investigations, making it an important provider in the digital forensics and investigative technology market.

CEO Mr. Shiven Ramji · 1,285 employees · Israel · https://www.cellebrite.com